Rationale for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis

Detroz, Bernard; Laurent, Stanislas; Honore, Pierre; Blaffart, Francine; Limet, Raymond; Meurisse, Michel

doi:10.1080/00015458.2004.11679577

Article (Scientific journals)

Rationale for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis

Detroz, Bernard; Laurent, Stanislas; Honore, Pierre et al.

2004 • In Acta Chirurgica Belgica, 104, p. 377-384

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/11705

DOI
10.1080/00015458.2004.11679577

PubMed
15469146

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

ACB,2004.377-383.CHIP.pdf

Publisher postprint (1.14 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Intraperitoneal chemotherapy; hyperthermia; peritoneal carcinomatosis

Abstract :

[en] Up to now, the prognosis of peritoneal carcinomatosis from GI tract cancers remains very poor. Intraperitoneal hyperthermic chemotherapy has been proposed in the prevention or treatment of peritoneal carcinomatosis. The rationale for this locoregional approach comes from a better knowledge of the physiopathology of the disease. Intraperitoneal chemotherapy achieves high local drug concentration with limited systemic toxicity. It should be performed during or immediately after surgery to be effective towards microscopic residual tumor cells. A synergistic cytotoxic effect has been demonstrated when heat is combined with antineoplastic drugs. Intraperitoneal hyperthermic chemotherapy might not be regarded as the panacée but as a promising step in the management of peritoneal carcinomatosis. Some randomized studies of gastric cancer with macroscopic serosal invasion have suggested the efficacy of hyperthermic intraperitoneal chemotherapy for the prevention of peritoneal carcinomatosis. In patients with peritoneal carcinomatosis, some studies suggest, in selected cases, the positive effect of hyperthermic intraperitoneal chemotherapy on survival, when combined with cytoreductive surgery.

Disciplines :

Surgery

Author, co-author :

Detroz, Bernard ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation

Laurent, Stanislas

Honore, Pierre ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation

Blaffart, Francine ; Centre Hospitalier Universitaire de Liège - CHU > Bloc opératoire chirurgie cardio-vasculaire

Limet, Raymond ; Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques

Meurisse, Michel ; Centre Hospitalier Universitaire de Liège - CHU > Chirurgie abdominale- endocrinienne et de transplantation

Language :

English

Title :

Rationale for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis

Publication date :

2004

Journal title :

Acta Chirurgica Belgica

ISSN :

1784-3421

eISSN :

2577-0160

Publisher :

Acta Medica Belgica, Bruxelles, Belgium

Volume :

104

Pages :

377-384

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 21 April 2009

Statistics

Number of views

95 (4 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

CHU D. Z., LANG N. P., THOMPSON C., OSTEEN P.K., WESTBROOK K. C. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer, 1989, 63(2) : 364-367.
ELIAS D., GACHOT B., BONVALLOT S., BLOT F, SABOURIN J. C., DUCREUX M., ROUGIER P., LASSER P. [Peritoneal carcinosis treated by complete excision and immediate postoperative intra-peritoneal chemotherapy. Phase II study in 54 patients]. Gastroenterol Clin Biol, 1997, 21(3) : 181-187.
MARKMAN M., REICHMAN B., HAKES T., CURTIN J., JONES W., LEWIS J. L., Jr., BARAKAT R., RUBIN S., MYCHALCZAK B., SAIGO P. Intraperitoneal chemotherapy in the management of ovarian cancer. Cancer, 1993, 71(4 Suppl) : 1565-1570.
SUGARBAKER P. H. Surgical management of peritoneal carcinosis : diagnosis, prevention and treatment. Langenbecks Arch Chir, 1988, 373(3) : 189-196.
SUGARBAKER P. H. Surgical treatment of peritoneal carcinomatosis : 1988 Du Pont lecture. Can J Surg, 1989, 32(3) : 164-170.
WOLF B. E., SUGARBAKER P. H. Intraperitoneal chemotherapy and immunotherapy. Recent Results Cancer Res, 1988, 110 : 254-273.
FERNANDEZ-TRIGO V., STUART O. A., STEPHENS A. D., HOOVER L. D., SUGARBAKER P. H. Surgically directed chemotherapy : heated intraperitoneal lavage with mitomycin C. Cancer Treat Res, 1996, 81 : 51-61.
JACQUET P., STEPHENS A. D., AVERBACH A. M., CHANG D., ETTINGHAUSEN S. E., DALTON R. R., STEVES M. A., SUGARBAKEr P. H. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer, 1996, 77(12) : 2622-2629.
KOGA S., HAMAZOE R., MAETA M., SHIMIZU N., KANAYAMA H., OSAKI Y. Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug. Cancer Res, 1984, 44(5) : 1840-1842.
SHIU M. H., FORTNER J. G. Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res, 1980, 40(11) : 4081-4084.
SUGARBAKER P. H., AVERBACH A. M., JACQUET P., STEPHENS A. D., STUART O. A. A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor. Cancer Treat Res, 1996, 82 : 415-421.
BEAUJARD A. C., GLEHEN O., CAILLOT J. L., FRANCOIS Y., BIENVENU J., PANTEIX G., GARBIT F., Grandclement E., Vignal J., Gilly F. N. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer, 2000, 88(11) : 2512-2519.
CEELEN W.P., HESSE U., DE HEMPTINNE B., PATTYN P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg, 2000, 87(8) : 1006-1015.
ELIAS D., SABOURIN J. C. [Pseudomyxoma peritonei. A review]. J Chir (Paris), 1999, 136(6) : 341-347.
ELIAS D., ANTOUN S., RAYNARD B., PUIZILLOUT J. M., SABOURIN J. C., DUCREUX M., LASSER P. [Treatment of peritoneal carcinomatosis using complete excision and intraperitoneal chemohyperthermia. A phase I-II study defining the best technical procedures]. Chirurgie, 1999, 124(4) : 380-389.
FUJIMOTO S., TAKAHASHI M., MUTOU T., KOBAYASHI K., TOYOSAWA T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer, 1999, 85(3) : 529-534.
JACQUET N. New philosophy in the treatment of peritoneal carcinomatosis of gastrointestinal origin. Bull Mem Acad R Med Belg, 1998, 153(10-11) : 414-425.
REY Y., PORCHERON J., TALABARD J. N., SZAFNICKI K., BALIQUE J. G. Peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemohyperthermia. Ann Chir, 2000, 125(7) : 631-642.
SUGARBAKER P. H., YONEMURA Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding : best palliation with a ray of hope for cure. Oncology, 2000, 58(2) : 96-107.
JACQUET P., ELIAS D., SUGARBAKER P. H. [Tumor implantation in cicatrization sites following surgery for digestive cancers]. J Chir (Paris), 1996, 133(4) : 175-182.
HANSEN E., WOLFE N., KNUECHEL R., RUSCHOFF J., HOFSTAEDTER F., TAEGER K. Tumor cells in blood shed from the surgical field. Arch Surg, 1995, 130(4) : 387-393.
LEATHER A. J., KOCJAN G., SAVAGE E, HU W., YIU C. Y., BOULOS P. B., NORTHOVER J. M., PHILLIPS R. K. Detection of free malignant cells in the peritoneal cavity before and after resection of colorectal cancer. Dis Colon Rectum, 1994, 37(8) : 814-819.
GERTSCH P., BAER H. U., KRAFT R., MADDERN G. J., ALTERMATT H. J. Malignant cells are collected on circular staplers. Dis Colon Rectum, 1992, 35(3) : 238-241.
WEISS L. Inefficiency of metastasis from colorectal carcinomas. Relationship to local therapy for hepatic metastasis. Cancer Treat Res, 1994, 69 : 1-11.
WEISS L. Metastatic inefficiency : intravascular and intraperitoneal implantation of cancer cells. Cancer Treat Res, 1996, 82 : 1-11.
BAKER D. G., MASTERSON T. M., PACE R., CONSTABLE W.C., WANEBO H. The influence of the surgical wound on local tumor recurrence. Surgery, 1989, 106(3) : 525-532.
ELIAS D. M., QUELLET J. F. Intraperitoneal chemohyperthermia : rationale, technique, indications, and results. Surg Oncol Clin N Am, 2001, 10(4): 915-33, xi.
SUGARBAKER P. H., CUNLIFFE W. J., BELLIVEAU J., DE BRUIJN E. A., GRAVES T., MULLINS R. E., SCHLAG P. Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol, 1989, 16(4 Suppl 6) : 83-97.
GUILLOU P. J. Adjuvant biological response modifiers after major surgery or trauma. Br J Surg, 1995, 82(6) : 721-723.
LITTLE D., REGAN M., KEANE R. M., BOUCHIER-HAYES D. Perioperative immune modulation. Surgery, 1993, 114(1) : 87-91.
DEDRICK R. L. Theoretical and experimental bases of intraperitoneal chemotherapy. Semin Oncol, 1985, 12(3 Suppl 4) : 1-6.
ELIAS D., BONNAY M., PUIZILLOU J. M., ANTOUN S., DEMIRDJIAN S., EL O. A., PIGNON J. P., DROUARD-TROALEN L., QUELLET J. F., DUCREUX M. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol, 2002, 13(2) : 267-272.
LOS G., MUTSAERS P. H., LENGLET W. J., BALDEW G.S., MCVIE J. G. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment. Cancer Chemother Pharmacol, 1990, 25(6) : 389-394.
LOS G., VAN VUGT M. J., PINEDO H. M. Response of peritoneal solid tumours after intraperitoneal chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer, 1994, 69(2) : 235-241.
OLESON J. R., CALDERWOOD S. K., COUGHLIN C. T., DEWHIRST M. W., GERWECK L. E., GIBBS F. A., Jr., KAPP D. S. Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol, 1988, 11(3) : 368-380.
OLESON J. R. What is regional hyperthermia ? Int J Hyperthermia, 1987, 3(3) : 281-284.
HILDEBRANDT B., WUST P., AHLERS O., DIEING A., SREENIVASA G., KERNER T., FELIX R., RIESS H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol, 2002, 43(1) : 33-56.
BARLOGIE B., CORRY P. M., Drewinko B. In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammine-platinum(II) and mitomycin C. Cancer Res, 1980, 40(4) : 1165-1168.
MEYN R. E., CORRY P. M., FLETCHER S. E., Demetriades M. Thermal enhancement of DNA damage in mammalian cells treated with cis- diamminedichloroplatinum(II). Cancer Res, 1980, 40(4) : 1136-1139.
HAMAZOE R. [Experimental studies on continuous hyperthermic peritoneal perfusion in the treatment for peritoneal metastases of cancer]. Nippon Geka Gakkai Zasshi, 1983, 84(11) : 1117-1129.
DETROZ B,. ELIAS D., DAMIA E., DEBAENE B., ROUGIER P., LASSER P. Intraperitoneal hyperthermic chemotherapy (IPHC), a promising treatment of peritoneal carcinomatosis. Bull Cancer, 1994, 81(3) : 182-193.
ELIAS D., DETROZ B., DEBAENE B., DAMIA E., LECLERCQ B., ROUGIER P., LASSER P. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. Hepatogastroenterology, 1994, 41(3) : 207-213.
ELIAS D., ANTOUN S., GOHARIN A., OTMANY A. E., PUIZILLOUT J. M., LASSER P. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig, 2000, 1(5) : 431-439.
FUJIMOTO S., SHRESTHA R. D., KOKUBUN M., OHTA M., TAKAHASHI M., KOBAYASHI K., KIUCHI S., OKUI K., MIYOSHI T, ARIMIZU N. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg, 1988, 208(1): 36-41.
FUJIMURA T., YONEMURA Y., FUSHIDA S., URADE M., TAKEGAWA S., KAMATA T., SUGIYAMA K., HASEGAWA H., KATAYAMA K., MIWA K. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer, 1990, 65(1) : 65-71.
GILLY F. N., BEAUJARD A., GLEHEN O., GRANDCLEMENT E., CAILLOT J. L., FRANCOIS Y., SADEGHI-LOOYEH B., GUEUGNIAUD P. Y., GARBIT F., BENOIT M., BIENVENU J., VIGNAL J. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis : phase I-II study. Anticancer Res, 1999, 19(3B) : 2317-2321.
MANSVELT B., BERTRAND C., NOCKERMAN P., ARNOULD P., DELVAUX P., LECHIEN X., DE NEVE R. [Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis]. Ann Chir, 1997, 51(1) : 60-67.
SCHNEEBAUM S., ARNOLD M. W., STAUBUS A., YOUNG D. C., DUMOND D., MARTIN E. W., Jr. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol, 1996, 3(1) : 44-50.
AKIYAMA H., YAMAOKA H., TANAKA K., ISHIKAWA T., ICHIKAWA Y., WAKASUGI J., NAGASHIMA Y., SHIMADA H. Continuous hyperthermic peritoneal perfusion for peritoneal dissemination of gastric cancer. Hepatogastroenterology, 1998, 45(24) : 2079-2086.
DE BREE E., WITKAMP A. J., ZOETMULDER F. A. Peroperative hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer. Eur J Surg Oncol, 2000, 26(6) : 630-632.
HAMAZOE R., MAETA M., KAIBARA N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer, 1994, 73(8) : 2048-2052.
HIROSE K., KATAYAMA K., IIDA A., YAMAGUCHI A., NAKAGAWARA G., UMEDA S., KUSAKA Y. Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer : evaluation by multivariate regression analysis. Oncology, 1999, 57(2) : 106-114.
KAIBARA N., HAMAZOE R., IITSUKA Y., MAETA M., KOGA S. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer. Hepatogastroenterology, 1989, 36(2) : 75-78.
KAIBARA N. [Prophylaxis and treatment of peritoneal metastasis from gastric cancer]. Nippon Geka Gakkai Zasshi, 1996, 97(4) : 308-311.
KUSANO H., MIYASHITA K., MATSUO T., JIBIKI M., NAKAGOE T., MIURA T., TOMITA M. [Continuous hyperthermic peritoneal perfusion (CHPP) for prevention or treatment of peritoneal dissemination]. Gan To Kagaku Ryoho, 1993, 20(11) : 1622-1625.
YONEMURA Y., NINOMIYA I., KAJI M., SUGIYAMA K., FUJIMURA K., SAWA T., KATAYAMA K., TANAKA S., HIRONO Y., MIWA K., Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg, 1995, 19(3) : 450-454.
ALEXANDER H. R., FRAKER D. L. Treatment of peritoneal carcinomatosis by continuous hyperthermic peritoneal perfusion with cisplatin. Cancer Treat Res, 1996, 81 : 41-50.
CHUNG Y. C., HUANG M. T., CHANG C. N., HUANG T. W. Continuous hyperthermic peritoneal perfusion for peritoneal carcinomatosis. J Formos Med Assoc, 1996, 95(2) : 138-143.
ELIAS D., BLOT F., EL OTMANY A., ANTOUN S., LASSER P., BOIGE V., ROUGIER P., DUCREUX M. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer, 2001, 92(1) : 71-76.
ELIAS D., POCARD M., SIDERIS L., EDE C., DUCREUX M., BOIGE V., LASSER P. Preliminary results of intraperitoneal chemohyperthermia with oxaliplatin in peritoneal carcinomatosis of colorectal origin. Br J Surg, 2004, 91(4) : 455-456.
FUJIMOTO S., TAKAHASHI M., KOBAYASHI K., KASANUKI J., OHKUBO H. Heated intraperitoneal mitomycin C infusion treatment for patients with gastric cancer and peritoneal metastasis. Cancer Treat Res, 1996, 81 : 239-245.
MA G. Y., BARTLETT D. L., REED E., FIGG W. D., LUSH R. M., LEE K. B., LIBUTTI S. K., ALEXANDER H. R. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma. Cancer J Sci Am, 1997, 3(3) : 174-179.
SUGARBAKER P. H., LANDY D., PASCAL R. Intraperitoneal chemotherapy for peritoneal carcinomatosis from colonie or appendiceal cystadenocarcinoma: rationale and results of treatment. Prog Clin Biol Res, 1990, 354B : 141-170.
SUGARBAKER P. H. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol, 2001, 27(3) : 239-243.
WITKAMP A. J., DE BREE E., KAAG M. M., BOOT H., BEIJNEN J. H., VAN SLOOTEN G. W., VAN COEVORDEN F., ZOETMULDER F. A. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer, 2001, 37(8) : 979-984.
YONEMURA Y., FUJIMURA T., NISHIMURA G., FALLA R., SAWA T., KATAYAMA K., TSUGAWA K., FUSHIDA S., MIYAZAKI I., TANAKA M., ENDOU Y., SASAKI T. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery, 1996, 119(4) : 437-444.
SUGARBAKER P. H. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharmacol, 1999, 43 Suppl : S15-25 : S15-S25.
ELIAS D., SIDERIS L., POCARD M., EDE C., BEN HASSOUNA D., DUCREUX M., BOIGE V., COTE J. F., LASSER P. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol, 2004, 15(5) : 781-785.
VERWAAL V. J., VAN RUTH S., DE BREE E., VAN SLOOTHEN G. W., VAN TINTEREN H., BOOT H., ZOETMULDER F. A. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol, 2003, 21(20) : 3737-3743.